{"entity":{"type":"insider","cik":"0001718648","url":"/insider/0001718648","json_url":"/insider/0001718648.json","name":"Murray Christopher K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2020-03-11","last":"2024-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Murray Christopher K.","source":"filing","n_filings":11,"first_seen":"2020-03-11","last_seen":"2024-03-11"}],"transactions":[{"id":2601418,"accession":"0001415889-24-007558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007558","line_url":"/filing/0001415889-24-007558#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2521.0,"shares_display":"2,521","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":228629.49,"total_display":"228,629.49","total_whole":"228,629","shares_owned_after":33853.0,"shares_owned_after_display":"33,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2562974,"accession":"0001415889-24-006954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006954","line_url":"/filing/0001415889-24-006954#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":93.65,"price_display":"93.65","price_state":"stated","total_value":58156.65,"total_display":"58,156.65","total_whole":"58,157","shares_owned_after":36374.0,"shares_owned_after_display":"36,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":3052840,"accession":"0001415889-24-006053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006053","line_url":"/filing/0001415889-24-006053#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":24495.0,"shares_owned_after_display":"24,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-03-01","scope":"insider"},{"id":8480252,"accession":"0001415889-23-016209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-016209","line_url":"/filing/0001415889-23-016209#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","total_whole":"375,000","shares_owned_after":24495.0,"shares_owned_after_display":"24,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-11","scope":"insider"},{"id":7826785,"accession":"0001415889-23-015946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015946","line_url":"/filing/0001415889-23-015946#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":71.43,"price_display":"71.43","price_state":"stated","total_value":42858.0,"total_display":"42,858.00","total_whole":"42,858","shares_owned_after":24495.0,"shares_owned_after_display":"24,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":8710983,"accession":"0001415889-23-014586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-014586","line_url":"/filing/0001415889-23-014586#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":56.4,"price_display":"56.40","price_state":"stated","total_value":33840.0,"total_display":"33,840.00","total_whole":"33,840","shares_owned_after":25095.0,"shares_owned_after_display":"25,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-26","filed_date":"2023-10-30","scope":"insider"},{"id":8087080,"accession":"0001415889-23-004566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004566","line_url":"/filing/0001415889-23-004566","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (CHIEF TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1875.0,"shares_display":"1,875","price_per_share":45.675408,"price_display":"45.68","price_state":"stated","total_value":85641.39,"total_display":"85,641.39","total_whole":"85,641","shares_owned_after":25741.0,"shares_owned_after_display":"25,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6905174,"accession":"0001415889-22-008385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-008385","line_url":"/filing/0001415889-22-008385#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":162500.0,"total_display":"162,500.00","total_whole":"162,500","shares_owned_after":18820.0,"shares_owned_after_display":"18,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":6905169,"accession":"0001415889-22-008385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-008385","line_url":"/filing/0001415889-22-008385#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":60.44,"price_display":"60.44","price_state":"stated","total_value":151100.0,"total_display":"151,100.00","total_whole":"151,100","shares_owned_after":21320.0,"shares_owned_after_display":"21,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-08","scope":"insider"},{"id":6867688,"accession":"0001415889-22-002737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-002737","line_url":"/filing/0001415889-22-002737#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":502.0,"shares_display":"502","price_per_share":56.19,"price_display":"56.19","price_state":"stated","total_value":28207.38,"total_display":"28,207.38","total_whole":"28,207","shares_owned_after":23820.0,"shares_owned_after_display":"23,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6867685,"accession":"0001415889-22-002737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002737","line_url":"/filing/0001415889-22-002737#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark":"O","role_mark_label":"Officer (SVP, TECHNICAL OPERATIONS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, TECHNICAL OPERATIONS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1066.0,"shares_display":"1,066","price_per_share":60.27,"price_display":"60.27","price_state":"stated","total_value":64247.82,"total_display":"64,247.82","total_whole":"64,248","shares_owned_after":24322.0,"shares_owned_after_display":"24,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-08","scope":"insider"},{"id":5216922,"accession":"0001179110-21-003008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-003008","line_url":"/filing/0001179110-21-003008","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1210.0,"shares_display":"1,210","price_per_share":86.76336363636364,"price_display":"86.76","price_state":"stated","total_value":104983.67,"total_display":"104,983.67","total_whole":"104,984","shares_owned_after":18888.0,"shares_owned_after_display":"18,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-05","scope":"insider","n_lines":2},{"id":3186559,"accession":"0001179110-20-003469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003469","line_url":"/filing/0001179110-20-003469#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001718648","owner_name":"Murray Christopher K.","owner_display_name":"Murray Christopher K.","owner_url":"/insider/0001718648","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":402.0,"shares_display":"402","price_per_share":51.94,"price_display":"51.94","price_state":"stated","total_value":20879.88,"total_display":"20,879.88","total_whole":"20,880","shares_owned_after":13848.0,"shares_owned_after_display":"13,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (CHIEF TECHNICAL OPERATIONS)","n_filings":11,"first_seen":"2020-03-11","last_seen":"2024-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001718648","retrieved_at":"2026-08-24T22:50:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}